This study investigated the role of brain angiotensin (Ang II) in thir
st induced by hemorrhage. Hemorrhage by blood withdrawal from the femo
ral artery to 33% and 44% blood volume loss produces a dose response i
ncrease in plasma Ang II. In the brainstem there was no Ang II respons
e to hemorrhage. In the hypothalamus, Brain Ang II was maximally eleva
ted to 33% hemorrhage. Thus, plasma Ang II and brain Ang II had an ind
ependent response to hemorrhage. To further test the role of central v
ersus peripheral Ang II, we tested the effect of central (50 mg) and p
eripheral (50 mg/kg) administration of captopril or central injection
of 1 mg losartan or 3 mg CGP 42112A prior to a 33% hemorrhage in unane
sthetized male Sprague-Dawley rats (250 g). Drinking was measured and
AVP blood samples were taken before and after hemorrhage. The results
show that central (ivt) administration of captopril and losartan inhib
ited drinking compared to controls (0.33 +/- 0.3 mi vs. 2.3 +/- 0.8 mi
: P < 0.05 and 0.20 +/- 0.09 mi vs. 3.05 +/- 0.81 ml; P < 0.01, respec
tively) while peripheral tip) captopril alone increased drinking in re
sponse to hemorrhage (5.81 +/- 0.81 ml vs. 2.3 +/- 0.8 ml, P < 0.05).
AVP levels were elevated at 5 and 15 min, but neither injections of lo
sartan or CGP 42112A i.v.t. affected this response to hemorrhage. We c
onclude that increased hypothalamic brain Ang II after hypovolemic hem
orrhage stimulates thirst and blood pressure restoration and acts thro
ugh AT, receptors. The release of AVP in hemorrhage, however, does not
rely exclusively on the angiotensinergic pathway in the brain.